Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar rtrieone (< 20) Submitted: 4/9/2007 9:08:39 PM : Outperform Start Price: $12.24 ASTM Score: -80.01


They will need time to get the studies done. This stuff works and very exciting to see it all come alive and make a lot of money investing....

Featured Broker Partners


Advertisement